AKT1 and hepatocellular carcinoma: Furthermore, in vitro experiments have shown that treatment of HCC cells with HYD-PEP06, an endostatin-derived synthetic polypeptide, inhibits metastasis by suppressing EMT through blocking of PI3K/AKT signaling pathway (Table 1).